Attached files

file filename
EX-99.1 - TRANSCRIPT OF CONFERENCE CALL HELD ON JANUARY 26, 2012 - NEXTGEN HEALTHCARE, INC.d292331dex991.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K/A

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) January 25, 2012

 

 

QUALITY SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

CALIFORNIA   001-12537   95-2888568

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification Number)

18111 Von Karman, Suite 700

Irvine, California 92612

(Address of Principal Executive Offices)

(949) 255-2600

(Registrant’s Telephone Number, Including Area Code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02 Results of Operations and Financial Condition.

As indicated on the Form 8-K filed on January 26, 2012, Quality Systems, Inc. (the “Company”) held an investor conference call, which included certain financial information relating to the period ended December 31, 2011. The conference call was announced by a widely disseminated press release and was made available to the public via audio webcast through the Company’s website. A copy of the transcript from the conference call concerning the aforementioned financial information is attached to this Form 8-K/A as Exhibit 99.1. The conference call contained forward-looking statements regarding the Company and included cautionary statements identifying important factors that could cause actual results to differ materially from those anticipated.

The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 to this Form 8-K/A shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.

 

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

As previously announced by the Company, Mr. Patrick B. Cline retired from his position as the Company’s President and Chief Strategy Officer, effective December 1, 2011. On January 25, 2012, the Board of Directors (the “Board”) of the Company appointed Mr. Steven T. Plochocki as President of the Company to fill the vacancy created by Mr. Cline’s retirement.

Mr. Plochocki, age 60, has served as the Company’s Chief Executive Officer since August 2008 and as a member of the Board since September 2004. From February 2007 to May 2008, he served as Chairman and Chief Executive Officer of Omniflight Helicopter, Inc., a Dallas-based air medical services company. From October 2006 to February 2007, Mr. Plochocki was a private healthcare investor. He also previously served as Chief Executive Officer and Director of Trinity Hospice, a national hospice provider from October 2004 through October 2006. Prior to joining Trinity Hospice, he was Chief Executive Officer of InSight, a national provider of diagnostic imaging services from November 1999 to August 2004. Following his appointment as President, Mr. Plochocki will continue to serve the Company as the President and Chief Executive Officer, and as a member of the Board. The Board did not make any changes to Mr. Plochocki existing employment or compensation arrangements with the Company in connection with his new responsibilities and change in title.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit No.

  

Description

99.1    Transcript of conference call held on January 26, 2012

 

-2-


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 31, 2012

 

QUALITY SYSTEMS, INC.
By:  

/s/ PAUL HOLT

  Paul Holt
  Chief Financial Officer

 

-3-


EXHIBITS ATTACHED TO THIS REPORT ON FORM 8-K/A

 

Exhibit No.

  

Description

99.1    Transcript of conference call held on January 26, 2012

 

-4-